Location
1309 HSLC
Date
Thursday, April 18, 2013
Time
12:00PM - 1:00PM
Abstract
"The treatment of HER2-driven cancer through the inactivation of HER2; the third decade".
Speaker(s)
Dr. Mark Moasser
Affiliation
Division of Hematology/Oncology, University of California, San Francisco
Sponsor
Department of Human Oncology
More Info
Pat Lee @ lee@humonc.wisc.edu